Genomic scarring score as a criterion for PARP inhibitor administration in early-stage NSCLC

被引：0
|
作者：
Klinakis, A. [1 ]
Tsilingiri, K. [1 ]
Chalari, A. [1 ]
Voutsina, A. [2 ]
Christopoulou, G. [3 ]
Vatselas, G. [4 ]
Potaris, K. [5 ]
Vamvakaris, I. [6 ]
Hatzidaki, D. [7 ]
Zachou, G. [8 ]
Georgoulias, V. [7 ]
Konstantoulakis, P. [3 ]
Kotsakis, A. [9 ]
机构：
[1] Biomed Res Fdn Acad Athens BRFAA, Ctr Basic Res, Athens, Greece
[2] Natl Hellen Res Fdn, Inst Chem Biol, Athens, Greece
[3] Genotypos Sci Labs, Mol Genet, Athens, Greece
[4] Biomed Res Fdn Acad Athens BRFAA, Greek Genome Ctr, Athens, Greece
[5] SOTIRIA Gen Hosp Athens, Dept Thorac Surg, Athens, Greece
[6] Sotiria Thorac Dis Hosp Athens, Dept Pathol, Athens, Greece
[7] Hellen Oncol Res Grp, Athens, Greece
[8] Metropolitan Gen Hosp, Oncol, Cholargos, Greece
[9] Univ Thessaly, Med Oncol Dept, Larisa, Greece
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
基金：
欧盟地平线“2020”;
关键词：
D O I：
10.1016/j.annonc.2024.08.1292
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1233P
引用
收藏
页码：S791 / S791
页数：1
相关论文
共 50 条
  • [31] EXPRESSION OF ANGIOGENIC AND LYMPHANGIOGENIC GENES AS BIOMARKERS OF PROGNOSIS IN EARLY-STAGE NSCLC
    Sanmartin, Elena
    Jantus Lewintre, Eloisa
    Sirera, Rafael
    Gallach, Sandra
    Uso, Marta
    Blasco, Ana
    Hernando, Cristina
    Palomares, Eugenio
    Guijarro, Ricardo
    Camps, Carlos
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1022 - S1023
  • [32] Pleural Contact in Clinical Early-Stage NSCLC: Recurrence Patterns and Survival
    Feinstein, S.
    Usera, B. M.
    Ahmed, A.
    Aldin, M. A. Kamal
    Daly, M. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E372 - E373
  • [33] Stereotactic lung radiotherapy for early-stage NSCLC: An institution's experience
    Ferreira, N.
    Travancinha, C.
    Antunes, T.
    Fonseca, J.
    Labareda, M.
    Santos, F.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : S56 - S56
  • [34] Immune characteristics associated with lymph node metastasis in early-stage NSCLC
    Ziyu Zhang
    Li Li
    Yang Gao
    Xiaoxiong Xiao
    Liyan Ji
    Zhipeng Zhou
    Juan Jiang
    Shiqing Liu
    Jian An
    Pengbo Deng
    NanNan Du
    Pansong Li
    Xuefeng Xia
    Chengping Hu
    Min Li
    Cellular Oncology, 2024, 47 : 447 - 461
  • [35] Biomarker testing in early-stage NSCLC: Results from the MYLUNG Consortium
    Evangelist, Makenzi Colleen
    Butrynski, James Edward
    Paschold, John C.
    Ward, Patrick J.
    Waterhouse, David Michael
    Spira, Alexander I.
    Ali, Kashif
    Hakimian, David
    Jotte, Robert M.
    Larson, Timothy
    Meshad, Michael W.
    Owera, Rami
    Richards, Donald A.
    Neubauer, Marcus A.
    Robert, Nicholas J.
    Yori, Jennifer L.
    Pant, Manoj
    Coleman, Robert L.
    Spigel, David R.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [36] Tumor response and toxicity in neoadjuvant erlotinib in early-stage NSCLC patients
    Klomp, H. M.
    Schaake, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [37] Immune characteristics associated with lymph node metastasis in early-stage NSCLC
    Zhang, Ziyu
    Li, Li
    Gao, Yang
    Xiao, Xiaoxiong
    Ji, Liyan
    Zhou, Zhipeng
    Jiang, Juan
    Liu, Shiqing
    An, Jian
    Deng, Pengbo
    Du, Nannan
    Li, Pansong
    Xia, Xuefeng
    Hu, Chengping
    Li, Min
    CELLULAR ONCOLOGY, 2024, 47 (02) : 447 - 461
  • [38] Circulating tumor DNA in early-stage NSCLC: A lung TRACERx study
    Abbosh, Christopher
    CLINICAL CANCER RESEARCH, 2018, 24 (17)
  • [39] Surgical salvage following stereotactic body radiotherapy for early-stage NSCLC
    Allibhai, Z.
    Cho, B. C. J.
    Taremi, M.
    Atallah, S.
    Hope, A.
    Hwang, D.
    Keshavjee, S.
    Tsao, M.
    Yasufuku, K.
    Kim, S-W.
    Bezjak, A.
    EUROPEAN RESPIRATORY JOURNAL, 2012, 39 (04) : 1039 - 1042
  • [40] Pemetrexed in combination with cisplatin or carboplatin as adjuvant chemotherapy in early-stage NSCLC
    Schmid-Bindert, G.
    Chemaissani, A.
    Fischer, J. R.
    Schuette, W.
    Mazieres, J.
    Vinolas, N.
    Wolf, M.
    Vaury, A. Thareau
    Leschinger, M.
    Reck, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345